{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 32,
  "pageCount": 366,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a narrative of past professional failure to cast doubt on current leadership.",
  "elementsJson": [
    "paragraph",
    "headshot",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/32",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-32",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "A biotech with no IP is, of course, a house of cards - typical of a Jeff Aronin rig.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccb-1bc6c519d6c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.07,
        "y": 0.53
      },
      "kind": "image",
      "text": "Jeff Aronin, Harmony founder and executive chairman",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "faf005f0-6bcb-4385-8aad-d96278b38cc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.56,
        "x": 0.37,
        "y": 0.53
      },
      "kind": "other",
      "text": "Carter-Wallace Issues Epilepsy Drug Warning. NEW YORK — Drug maker Carter-Wallace Inc. told doctors Monday to take their patients off the epilepsy drug Felbatol after two people who took it died from a serious form of anemia, a development that led to the company’s stock losing a third of its value.",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c997ec06-6618-4372-8249-8952a427cd3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "He was interviewed by a local radio station in 2021, where he stated his first job out of college was selling a pediatric epilepsy drug for Carter-Wallace. The interviewer notes that “he was upset to see the company pull off the market a therapy that...helped many families because a side effect was discovered.” We presume the drug was felbatol, which was implicated in fatalities and remains one of the most infamous cases of post-approval toxicity. It is one thing to be a naïve drug rep in his early 20’s – quite another to be a 55-year old who still has a grudge about it.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9db9f6b9-d6f4-4ad3-a322-3b69038d5785",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "A biotech with no IP is, of course, a house of cards - typical of a Jeff Aronin rig. Aronin is a serial biotech promoter with a notorious history. His fetish for dressing up and pushing toxic CNS drugs seems to have begun in his youth.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b40ecb33-8613-4f12-9b11-63c915c1b414",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "he was upset to see the company pull off the market a therapy that...helped many families because a side effect was discovered. — Interviewer (referencing Jeff Aronin)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccb-1d2953f6df0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.07,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: https://www.wuwm.com/2021-08-25/how-jeff-aronin-began-building-life-sciences-companies-and-never-stopped; https://www.latimes.com/archives/la-xpm-1994-08-02-fi-22645-story.html",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dddf5666-47f6-442a-9d1f-25b239f1947b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 50,
      "from": 31,
      "beatId": "2b789ae4-940c-4d3a-9f03-7f2e7e4f46fd",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": null,
      "evidence": "The document presents the struggle of the company's critics and short-sellers to expose the truth",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}